Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial-Reference-Cited by-同舟云学术

Regorafenib plus modified FOLFOX6 as first-line treatment of metastatic colorectal cancer: A phase II trial

Published:2015-05 Issue:8 Volume:51 Page:942-949
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Argilés Guillem,Saunders Mark P.,Rivera Fernando,Sobrero Alberto,Benson Al,Guillén Ponce Carmen,Cascinu Stefano,Van Cutsem Eric,Macpherson Iain R.,Strumberg Dirk,Köhne Claus-Henning,Zalcberg John,Wagner Andrea,Luigi Garosi Vittorio,Grunert Julia,Tabernero Josep,Ciardiello Fortunato

Funder

Succinct Medical Communications

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference18 articles.

1. Globocan. Colorectal cancer. Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx; [last accessed 27.10.14].

2. Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Van Cutsem;Ann Oncol,2014

3. Liver resection for metastatic colorectal cancer in the age of neoadjuvant chemotherapy and bevacizumab;Yoo;Clin Colorectal Cancer,2006

4. Metastatic colon cancer, version 3.2013: featured updates to the NCCN Guidelines;Benson;J Natl Compr Canc Netw,2013

5. Regorafenib (BAY 73–4506): a new oral multikinase inhibitor of angiogenic, stromal and oncogenic receptor tyrosine kinases with potent preclinical antitumor activity;Wilhelm;Int J Cancer,2011

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study;Cancer Chemotherapy and Pharmacology;2024-07-10

2. Minimally invasive intervention combined with targeted immunotherapy achieves complete clinical response in advanced colorectal cancer: a case study and literature review;Minerva Biotechnology and Biomolecular Research;2024-05

3. Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments;Cancer and Metastasis Reviews;2023-12-19

4. A review of targeted therapy and immune checkpoint inhibitors for metastatic colorectal cancer;Surgical Oncology;2023-12

5. Erratum for the Research Article: “Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis”;Science Advances;2023-11-10